Perrigo (NYSE:PRGO) Reaches New 1-Year Low – What’s Next?

Shares of Perrigo Company plc (NYSE:PRGO) hit a new 52-week low during trading on Monday . The stock traded as low as $10.14 and last traded at $10.1530, with a volume of 725729 shares changing hands. The stock had previously closed at $10.72.

Wall Street Analyst Weigh In

Several research firms have issued reports on PRGO. JPMorgan Chase & Co. lowered their price target on shares of Perrigo from $20.00 to $18.00 and set a “neutral” rating for the company in a report on Monday, December 15th. Canaccord Genuity Group lowered their target price on shares of Perrigo from $20.00 to $17.00 and set a “buy” rating for the company in a research note on Friday, February 27th. Zacks Research raised shares of Perrigo from a “strong sell” rating to a “hold” rating in a research report on Friday, February 13th. Jefferies Financial Group reissued a “hold” rating on shares of Perrigo in a research report on Thursday, February 26th. Finally, Argus upgraded Perrigo to a “hold” rating in a research report on Wednesday, January 14th. One equities research analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Perrigo currently has a consensus rating of “Hold” and a consensus price target of $19.33.

Perrigo Stock Down 4.8%

The stock has a market cap of $1.41 billion, a price-to-earnings ratio of -0.99, a PEG ratio of 1.29 and a beta of 0.41. The stock has a 50 day simple moving average of $14.19 and a 200 day simple moving average of $16.99. The company has a quick ratio of 1.63, a current ratio of 2.76 and a debt-to-equity ratio of 1.23.

Perrigo (NYSE:PRGO) last issued its earnings results on Thursday, February 26th. The company reported $0.77 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.80 by ($0.03). Perrigo had a positive return on equity of 9.41% and a negative net margin of 33.51%.The firm had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.09 billion. During the same quarter in the prior year, the business earned $0.93 earnings per share. Perrigo’s revenue for the quarter was down 2.5% on a year-over-year basis. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. As a group, analysts expect that Perrigo Company plc will post 2.56 earnings per share for the current fiscal year.

Perrigo Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 24th. Shareholders of record on Monday, March 2nd will be issued a dividend of $0.29 per share. This represents a $1.16 dividend on an annualized basis and a yield of 11.4%. The ex-dividend date of this dividend is Monday, March 2nd. Perrigo’s payout ratio is currently -11.28%.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of PRGO. Amundi raised its position in Perrigo by 11.7% in the 1st quarter. Amundi now owns 5,292 shares of the company’s stock valued at $148,000 after buying an additional 556 shares during the last quarter. Goldman Sachs Group Inc. boosted its holdings in Perrigo by 126.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,159,768 shares of the company’s stock worth $32,520,000 after acquiring an additional 647,982 shares during the last quarter. United Services Automobile Association purchased a new stake in shares of Perrigo in the first quarter valued at about $250,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Perrigo by 6.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 513,112 shares of the company’s stock valued at $14,388,000 after purchasing an additional 32,151 shares during the last quarter. Finally, Geneos Wealth Management Inc. lifted its position in shares of Perrigo by 439.1% during the first quarter. Geneos Wealth Management Inc. now owns 965 shares of the company’s stock valued at $27,000 after purchasing an additional 786 shares in the last quarter. Hedge funds and other institutional investors own 95.91% of the company’s stock.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.